SE390303B - Forfarande for framstellning av isotiokarbamider med h?712-blockerande effekt - Google Patents

Forfarande for framstellning av isotiokarbamider med h?712-blockerande effekt

Info

Publication number
SE390303B
SE390303B SE7014259A SE1425970A SE390303B SE 390303 B SE390303 B SE 390303B SE 7014259 A SE7014259 A SE 7014259A SE 1425970 A SE1425970 A SE 1425970A SE 390303 B SE390303 B SE 390303B
Authority
SE
Sweden
Prior art keywords
isotiocarbamids
procedure
preparation
blocking effect
blocking
Prior art date
Application number
SE7014259A
Other languages
English (en)
Swedish (sv)
Inventor
J W Black
G J Durant
J C Emmett
C R Ganellin
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of SE390303B publication Critical patent/SE390303B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
SE7014259A 1969-10-29 1970-10-22 Forfarande for framstellning av isotiokarbamider med h?712-blockerande effekt SE390303B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5289069 1969-10-29

Publications (1)

Publication Number Publication Date
SE390303B true SE390303B (sv) 1976-12-13

Family

ID=10465720

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7014259A SE390303B (sv) 1969-10-29 1970-10-22 Forfarande for framstellning av isotiokarbamider med h?712-blockerande effekt

Country Status (9)

Country Link
JP (1) JPS4917262B1 (enrdf_load_stackoverflow)
BE (1) BE758145A (enrdf_load_stackoverflow)
CA (1) CA953725A (enrdf_load_stackoverflow)
DE (1) DE2052692A1 (enrdf_load_stackoverflow)
FR (1) FR2070177B1 (enrdf_load_stackoverflow)
GB (1) GB1296544A (enrdf_load_stackoverflow)
IE (1) IE34665B1 (enrdf_load_stackoverflow)
SE (1) SE390303B (enrdf_load_stackoverflow)
ZA (1) ZA707150B (enrdf_load_stackoverflow)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA938556A (en) * 1970-06-25 1973-12-18 Smith Kline And French Laboratories Limited Pharmaceutical compositions containing thiourea derivatives
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
GR62452B (en) 1977-04-20 1979-04-12 Ici Ltd Preparation process of guanidine derivatives
US4262125A (en) * 1979-07-23 1981-04-14 American Home Products Corporation (1H-Imidazol-5-ylmethyl)isothioureas
IT1201523B (it) * 1982-05-18 1989-02-02 Angeli Inst Spa Eterociclilfenilfomramidine,processi per la loro preparazione e loro uso farmaceutico
US4520025A (en) * 1982-07-21 1985-05-28 William H. Rorer, Inc. Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
US5321039A (en) * 1990-04-13 1994-06-14 Societe Civile Bioprojet Method of inducing a histamine agonist action on H2 receptors
FR2660862B1 (fr) * 1990-04-13 1994-09-23 Bioprojet Soc Civ Application therapeutique de derives de l'histamine, nouveau derive de l'histamine et utilisation de ces derives pour la preparation de medicaments.
NL9100365A (nl) * 1991-02-27 1992-09-16 Seed Capital Investments Imidazoolderivaten met agonistische of antagonistische activiteit op de histamine h3-receptor.
ATE159248T1 (de) * 1991-02-27 1997-11-15 Seed Capital Investments Imidazol-derivate mit antagonistischer aktivität auf den histamin-h3-receptor
GB0404434D0 (en) * 2004-02-27 2004-03-31 Novartis Ag Organic compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2548746A (en) * 1947-10-10 1951-04-10 Sharp & Dohme Inc S-(4-thiazolylmethyl)-isothioureas
IL25931A (en) * 1965-07-07 1972-01-27 Merck & Co Inc 4- or 5-nitroimidazole - and 5,6-dihydroimidazole [A-2,1] pyrrole-7-il-carbamates and pseudo-thiourea new imidazoles and preparation

Also Published As

Publication number Publication date
FR2070177B1 (enrdf_load_stackoverflow) 1974-10-11
ZA707150B (en) 1971-07-28
GB1296544A (enrdf_load_stackoverflow) 1972-11-15
DE2052692A1 (de) 1971-05-06
FR2070177A1 (enrdf_load_stackoverflow) 1971-09-10
CA953725A (en) 1974-08-27
IE34665L (en) 1971-04-29
IE34665B1 (en) 1975-07-09
BE758145A (fr) 1971-04-28
JPS4917262B1 (enrdf_load_stackoverflow) 1974-04-27

Similar Documents

Publication Publication Date Title
SE401504B (sv) Forfarande for framstellning av diaryl-imidazoler med inflammationsinhiberande effekt
SE384211B (sv) Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner
SE382459B (sv) Forfarande for framstellning av xantonderivat.
SE390969B (sv) Forfarande for framstellning av 1,2,3,4-tetrahydro-7-halogen-6-sulfamyl-4-kinazolinoner
SE383887B (sv) Analogiforfarande for framstellning av alfa-amino-cyklohexadienyl-alkylen-penicilliner
SE409708B (sv) Forfarande for framstellning av 2,4-diamino-5-bensylpyrimidiner
SE393374B (sv) Forfarande for framstellning av 2-alkyl-2-dialkylamino-2, '6'-acetoxylidider med lokalestetisk effekt
SE385885B (sv) Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat
NO146189C (no) Anordning for fremstilling av kunst-kull-formlegemer
NO138883C (no) Fremgangsmaate for fremstilling av oksiranforbindelser
SE390303B (sv) Forfarande for framstellning av isotiokarbamider med h?712-blockerande effekt
SE399701B (sv) Forfarande for framstellning av hydroxyalkyldiamin
FI54316B (fi) Foerfarande foer framstaellning av adenosin-5'-karbonsyraderivat med kretsomloppsverkan
SE402451B (sv) Forfarande for framstellning av 14-desoxi-14-acetoximutilin
SE7511680L (sv) Forfarande for framstellning av furanderivat
SE394436B (sv) Forfarande for framstellning av 7-halogen-linkomyciner
SE380273B (sv) Forfarande for framstellning av tiopyrimidinderivat
SE384685B (sv) Forfarande for framstellning av linkomycinderivat
SE385011B (sv) Forfarande for framstellning av alfa-linkosaminider
SE394668B (sv) Forfarande for framstellning av 2-etylhexan-1-al
SE408418B (sv) Forfarande for framstellning av 5-fluor-pyrimidiner
SE380796B (sv) Forfarande for framstellning av cyklopentanderivat
SE380800B (sv) Analogiforfarande for framstellning av dibensodiazepiner och pyridobensodiazepiner
SE383738B (sv) Forfarande for framstellning av sulfamoyl-bensensulfonamider med terapeutiska egenskaper
SE380795B (sv) Forfarande for framstellning av tiokarbamider